Lewek, Joanna, Konopka, Agnieszka, Starostecka, Ewa, Penson, Peter E 
ORCID: 0000-0001-6763-1489, Maciejewski, Marek and Banach, Maciej
(2021)
Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in Poland.
JOURNAL OF CLINICAL MEDICINE, 10 (19).
4302-.
|
Text
Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in P.pdf - Published version Download (701kB) | Preview |
Abstract
<h4>Background</h4>Familial hypercholesterolemia (FH) is a genetic autosomal co-dominant metabolic disorder leading to elevated circulating concentrations of low-density lipoprotein cholesterol (LDL-C). Early development of atherosclerotic cardiovascular disease (ASCVD) is common in affected patients. We aimed to evaluate the characteristics and differences in the diagnosis and therapy of FH children and adults. <i>Methods</i>: All consecutive patients who were diagnosed with FH, both phenotypically and with genetic tests, were included in this analysis. All patients are a part of the European Atherosclerosis Society FH-Study Collaboration (FHSC) regional center for rare diseases at the Polish Mother's Memorial Hospital Research Institute (PMMHRI) in Lodz, Poland. <i>Results</i>: Of 103 patients with FH, there were 16 children (15.5%) at mean age of 9 ± 3 years and 87 adults aged 41 ± 16; 59% were female. Children presented higher mean levels of total cholesterol, LDL-C, and high-density lipoprotein cholesterol (HDL-C) measured at the baseline visit (TC 313 vs. 259 mg/dL (8.0 vs. 6.6 mmol/L), <i>p</i> = 0.04; LDL 247 vs. 192 mg/dL (6.3 vs. 4.9 mmol/L), <i>p</i> = 0.02, HDL 53 vs. 48 mg/dL (1.3 vs. 1.2 mmol/L), <i>p</i> = 0.009). Overall, 70% of adult patients and 56% of children were prescribed statins (rosuvastatin or atorvastatin) on admission. Combination therapy (dual or triple) was administered for 24% of adult patients. Furthermore, 13.6% of adult patients and 19% of children reported side effects of statin therapy; most of them complained of muscle pain. Only 50% of adult patients on combination therapy achieved their treatment goals. None of children achieved the treatment goal.<h4>Conclusions</h4>Despite a younger age of FH diagnosis, children presented with higher mean levels of LDL-C than adults. There are still urgent unmet needs concerning effective lipid-lowering therapy in FH patients, especially the need for greater use of combination therapy, which may allow LDL-C targets to be met in most of the patients.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | familial hypercholesterolemia, registry, lipid-lowering therapy, statins |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 10 Dec 2021 16:49 |
| Last Modified: | 01 Feb 2024 03:44 |
| DOI: | 10.3390/jcm10194302 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3145215 |
Dimensions
Dimensions
